Medicines for Malaria Venture Email Format

Non-profit OrganizationsGeneva, Switzerland51-200 Employees

Medicines for Malaria Venture (MMV) is a Geneva-based non-profit organization operating as a product development partnership focused on antimalarial drug research and development. Its core objective is to advance medicines that protect and treat vulnerable populations at risk of malaria and contribute toward eradication. MMV sustains impact through an extensive network of more than 375 partners, spanning pharmaceutical companies, academic institutions, and endemic-country organizations across 50 countries. This collaborative model bridges research and access, translating scientific advances into therapies for those most affected. In April 2026 MMV and GlaxoSmithKline announced the deployment of a novel cure for Plasmodium vivax malaria. As a global health-focused product development partnership, MMV coordinates research and facilitates access to new malaria medicines for populations in endemic regions through collaboration with public and private sector partners.

Get verified Medicines for Malaria Venture emails free

Company overview Employee directory